Back to search

Reduction in platelet counts as a mechanistic biomarker and guide for adaptive dose-escalation in phase I studies of the Bcl-2 family inhibitor ABT-263

Data up to Jan 2025

Published2008
Citations13
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Reduction in platelet counts as a mechanistic biomarker and guide for adaptive… (2008) – Journal of Clinical Oncology | Metascience Observatory Explorer